ALDER BIOPHARMACEUTICALS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●] Debt SecuritiesIndenture • February 23rd, 2017 • Alder Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 23rd, 2017 Company Industry JurisdictionINDENTURE, dated as of [●], 20 , among Alder BioPharmaceuticals, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
ALDER BIOPHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFWarrant Agreement • February 23rd, 2017 • Alder Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 23rd, 2017 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ALDER BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
ALDER BIOPHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • February 23rd, 2017 • Alder Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 23rd, 2017 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ALDER BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).